Last $4.27 USD
Change Today 0.00 / 0.00%
Volume 82.4K
RTIX On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

rti surgical inc (RTIX) Snapshot

Open
$4.25
Previous Close
$4.27
Day High
$4.31
Day Low
$4.21
52 Week High
05/6/14 - $5.00
52 Week Low
10/31/13 - $2.77
Market Cap
241.8M
Average Volume 10 Days
138.0K
EPS TTM
$-0.06
Shares Outstanding
56.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for RTI SURGICAL INC (RTIX)

rti surgical inc (RTIX) Related Bloomberg News

View More Bloomberg News

rti surgical inc (RTIX) Related Businessweek News

No Related Businessweek News Found

rti surgical inc (RTIX) Details

RTI Surgical, Inc., together with its subsidiaries, produces and sells orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. It processes donated human musculoskeletal and other tissues, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera, and dermal tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by utilizing its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes. The company’s implants are used in the fields of spine, sports medicine, surgical specialties, bone graft substitutes and general orthopedic, dental, and ortho fixation. RTI Surgical, Inc. markets its products through its direct distribution force, as well as through a network of independent distributors to hospitals and surgeons in the United States and internationally. The company was formerly known as RTI Biologics, Inc. and changed its name to RTI Surgical, Inc. in July 2013. RTI Surgical, Inc. was founded in 1997 and is headquartered in Alachua, Florida.

1,100 Employees
Last Reported Date: 03/10/14
Founded in 1997

rti surgical inc (RTIX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $547.0K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $332.3K
Executive Vice President of North American Sa...
Total Annual Compensation: $327.7K
Chief Scientific Officer and Executive Vice P...
Total Annual Compensation: $330.1K
Executive Vice President of Administration an...
Total Annual Compensation: $328.4K
Compensation as of Fiscal Year 2013.

rti surgical inc (RTIX) Key Developments

RTI Surgical Announces First Implantation of Strips Configuration for map3(R) Cellular Allogeneic Bone Graft

RTI Surgical Inc. announced that the first human implantation of the company's map3(R) Cellular Allogeneic Bone Graft Strips Allograft took place during an anterior lumbar interbody fusion (ALIF) procedure last week. The map3 Strips Allograft implant will expand the company's current cellular allogeneic bone graft portfolio when it launches later in 2014. Map3 Strips Allograft is an implant that contains the three essential elements necessary for bone formation in a single allograft: a three-dimensional osteoconductive scaffold, demineralized bone matrix (DBM) that demonstrates verified osteoinductive potential and multipotent adult progenitor (MAPC(R)) class cells that provide osteogeneic and angiogeneic signals to support the bone healing process. This moldable implant is designed for ease of use, and its flexible yet cohesive properties make it ideal for filling bone voids in applications such as small joint repair, irregular defects or as an onlay in the posterolateral spine.

RTI Surgical Inc. Presents at JMP Securities Healthcare Conference, Jun-24-2014 04:00 PM

RTI Surgical Inc. Presents at JMP Securities Healthcare Conference, Jun-24-2014 04:00 PM. Venue: The Westin New York Grand Central, 212 East 42nd Street, New York, NY 10017, United States.

RTI Surgical Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014; Provides Earnings Guidance for the Second Quarter Ending June 30, 2014; Revises Earnings Guidance Earnings Guidance Ending December 31, 2014

RTI Surgical Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company's revenues were $60,745,000 against $40,422,000 a year ago. The increase was primarily related to the addition of revenue from Pioneer acquisition. Operating loss was $3,488,000 against income $1,062,000 a year ago. Loss before income tax benefit was $3,843,000 against income $1,062,000 a year ago. Net loss was $2,310,000 against income $1,462,000 a year ago. Net loss applicable to common shares was $3,060,000 or $0.05 basic and diluted per share against income $1,462,000 or $0.03 basic and diluted per share a year ago. Adjusted net income was $407,000 or $0.01 diluted per share against $1,462,000 or $0.03 diluted per share a year ago. Net cash used in operating activities was $3,307,000 against $8,063,000 a year ago. Purchases of property, plant and equipment were $4,936,000 against $2,708,000 a year ago. Patent and acquired intangible asset costs were $217,000 against $98,000 a year ago. At the end of the first quarter, the company had $74.3 million of debt and approximately $10.2 million available under revolving credit facilities. For the second quarter ending June 30, 2014, the company expects revenues to be between $62 million and $63 million and net income per fully diluted common share to be approximately $0.02, based on 57 million fully diluted shares outstanding. Adjusted non-GAAP net income per diluted share expects to be $0.02. Based on results from the first quarter, the company is raising full year revenue guidance ending December 31, 2014. The company now expects full year revenues for 2014 to be between $248 million and $253 million, as compared to prior guidance of between $245 million and $250 million. On a non-GAAP basis, excluding a certain first quarter purchase accounting adjustment, the company expects full year net income per fully diluted common share to be in the range of $0.07 to $0.09 based on 57 million fully diluted common shares outstanding, as compared to prior guidance of $0.06 to $0.08. GAAP net income per diluted share expects to be $0.01 - 0.03. For 2014, the company anticipates being cash flow positive from operations.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RTIX:US $4.27 USD 0.00

RTIX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alphatec Holdings Inc $1.38 USD -0.01
Bacterin International Holdings Inc $0.69 USD -0.01
Exactech Inc $24.32 USD -0.10
ICU Medical Inc $61.27 USD +0.47
Orthofix International NV $34.30 USD -0.64
View Industry Companies
 

Industry Analysis

RTIX

Industry Average

Valuation RTIX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.1x
Price/Book 1.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RTI SURGICAL INC, please visit www.rtisurgical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.